Aurobindo Pharma Limited

Company Profile

Aurobindo Pharma Limited had its IPO on under the ticker symbol 524804.

The company operates in the Other sector and Other industry. Aurobindo Pharma Limited has a staff strength of 0 employees.

Stock update

Shares of Aurobindo Pharma Limited opened at ₹871.95 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹857.45 - ₹886, and closed at ₹871.3.

This is a +0.41% increase from the previous day's closing price.

A total volume of 68,293 shares were traded at the close of the day’s session.

In the last one week, shares of Aurobindo Pharma Limited have increased by +6.33%.

Aurobindo Pharma Limited's Key Ratios

Aurobindo Pharma Limited has a market cap of ₹485.45 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Aurobindo Pharma Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Aurobindo Pharma Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aurobindo Pharma Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 749.78%.

In Q2, Aurobindo Pharma Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Aurobindo Pharma Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aurobindo Pharma Limited’s profitability.

Aurobindo Pharma Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Aurobindo Pharma Limited stock pays annual dividends of ₹ per share, indicating a yield of 0.53% and a payout ratio of 8.89%.

Balance sheet and cash flow metrics

Total Assets

₹398.90 billion

Total Liabilities

₹114.94 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

8.89%

Aurobindo Pharma Limited ended 2025 with ₹398.90 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹398.90 billion while shareholder equity stood at ₹268.40 billion.

Aurobindo Pharma Limited ended 2025 with ₹0 in deferred long-term liabilities, ₹114.94 billion in other current liabilities, 585900000.00 in common stock, ₹267.81 billion in retained earnings and ₹5.96 billion in goodwill. Its cash balance stood at ₹43.96 billion and cash and short-term investments were ₹65.26 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹6.19 billion.

Aurobindo Pharma Limited’s total current assets stands at ₹215.46 billion while long-term investments were ₹0 and short-term investments were ₹4.41 billion. Its net receivables were ₹44.66 billion compared to accounts payable of ₹38.71 billion and inventory worth ₹85.11 billion.

In 2025, Aurobindo Pharma Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Aurobindo Pharma Limited paid ₹0.09 in dividends in 2025.

Other key metrics

Current Trading Price

₹871.3

52-Week High

₹887.2

52-Week Low

₹394.8169

Analyst Target Price

₹

Aurobindo Pharma Limited stock is currently trading at ₹871.3 per share. It touched a 52-week high of ₹887.2 and a 52-week low of ₹887.2. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹814.86 and 200-day moving average was ₹596.62 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.